Seeking Alpha published the below article 5 days ago. Since than Pliant is down 27%. According to Pareto analyst Dan Akschuti: Vicore seems to be the game-changing drug for IPF. It is the first IPF drug that turns a deadly disease into a survivable one. VIcore has much stronger results than Pliant does. Despite that … Continue reading SeekingAlpha Article: Sell Pliant, Buy Vicore. Pliant -27% in 5 days. VICORE UP NEXT